[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853
Sort by:

Chemotherapy-Induced Diarrhea (CID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chemotherapy-Induced Diarrhea (CID) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chemotherapy-Induced Diarrhea (CID) Drugs in Development by Stages, Target,...

May 2022 36 pages

Chemotherapy Induced Myelosuppression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chemotherapy Induced Myelosuppression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chemotherapy Induced Myelosuppression Drugs in Development by Stages, Targ...

May 2022 39 pages

Chemotherapy Induced Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chemotherapy Induced Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chemotherapy Induced Oral Mucositis Drugs in Development by Stages, Target,...

May 2022 43 pages

Chemotherapy Induced Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chemotherapy Induced Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chemotherapy Induced Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 40 pages

Childhood Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Childhood Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Childhood Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 59 pages

Chlamydia Trachomatis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chlamydia Trachomatis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chlamydia Trachomatis Infections Drugs in Development by Stages, Target, MoA, R...

May 2022 37 pages

Cholestasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cholestasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cholestasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 45 pages

Cholinergic Receptor Muscarinic (Muscarinic Acetylcholine Receptor or CHRM) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Cholinergic Receptor Muscarinic (Muscarinic Acetylcholine Receptor or CHRM) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Cholinergic R...

May 2022 136 pages

Cholinergic Receptor Nicotinic Subunit (Nicotinic Acetylcholine Receptor or CHRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Cholinergic Receptor Nicotinic Subunit (Nicotinic Acetylcholine Receptor or CHRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Choline...

May 2022 74 pages

Chordoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chordoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chordoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an ov...

May 2022 52 pages

Choroidal Neovascularization Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Choroidal Neovascularization Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Choroidal Neovascularization Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 67 pages

Choroideremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Choroideremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Choroideremia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 37 pages

Chronic Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Bronchitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 35 pages

Chronic Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Cough Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 51 pages

Chronic Cutaneous Lupus Erythematosus (CCLE) - Discoid Lupus Erythematosus (DLE) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Cutaneous Lupus Erythematosus (CCLE) - Discoid Lupus Erythematosus (DLE) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Cutaneous Lupus Erythem...

May 2022 40 pages

Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) Drugs...

May 2022 38 pages

Chronic Granulomatous Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Granulomatous Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Granulomatous Disease Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 40 pages

Chronic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Heart Failure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 70 pages

Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 97 pages

Chronic Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Liver Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 49 pages

Chronic Myelomonocytic Leukemia (CMML) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Myelomonocytic Leukemia (CMML) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Myelomonocytic Leukemia (CMML) Drugs in Development by Stages, Ta...

May 2022 92 pages

Chronic Thromboembolic Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Thromboembolic Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Thromboembolic Pulmonary Hypertension Drugs in Development...

May 2022 37 pages

Chronic Traumatic Encephalopathy (CTE) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Chronic Traumatic Encephalopathy (CTE) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Chronic Traumatic Encephalopathy (CTE) Drugs in Development by Stages, Ta...

May 2022 44 pages

Circadian Rhythm Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Circadian Rhythm Sleep Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Circadian Rhythm Sleep Disorders Drugs in Development by Stages, Target, MoA, R...

May 2022 39 pages

Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an...

May 2022 120 pages

Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Citrullinemia Type I (Arginosuccinate Synthetase Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Citrullinemia Type I (Arginosuccinate Synthetase De...

May 2022 35 pages

Claudin 18 (CLDN18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Claudin 18 (CLDN18) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Claudin 18 (CLDN18) Drugs in Development by Therapy Areas and Indicat...

May 2022 47 pages

Clostridium difficile Toxin A (toxA or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Clostridium difficile Toxin A (toxA or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Clostridium difficile Toxin A (toxA or...

May 2022 46 pages

Clostridium difficile Toxin B (toxB or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Clostridium difficile Toxin B (toxB or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Clostridium difficile Toxin B (toxB or...

May 2022 47 pages

CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 65 pages

Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 63 pages

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Coagulation Factor VIII (Antihemophilic Factor or AHF or Procoagulant Component or F8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Co...

May 2022 82 pages

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Coagul...

May 2022 59 pages

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Coagulation Factor...

May 2022 40 pages

Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 144 pages

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Collagen Alpha 1(VII) Chain (Long Chain Collagen or COL7A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Collagen Alpha 1(VII) Chain (...

May 2022 39 pages

Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Colon Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 62 pages

Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Community-Acquired Bacterial Pneumonia Drugs in Development by Stages, Ta...

May 2022 40 pages

Complement C1q Subcomponent Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement C1q Subcomponent Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Complement C1q Subcomponent Drugs in Development by Therapy A...

May 2022 36 pages

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 41 pages

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY C...

May 2022 52 pages

Complement Factor B (Glycine Rich Beta Glycoprotein or C3-C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement Factor B (Glycine Rich Beta Glycoprotein or C3-C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, M...

May 2022 38 pages

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Pla...

May 2022 47 pages

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 37 pages

Complicated Intra-Abdominal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Complicated Intra-Abdominal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Complicated Intra-Abdominal Infections Drugs in Development by Stages, Ta...

May 2022 56 pages

Complicated Skin and Skin Structure Infections (cSSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Complicated Skin and Skin Structure Infections (cSSSI) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Complicated Skin And Skin Structure Infections (cSSSI) Dr...

May 2022 35 pages

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Congenital Adrenal Hyperplasia (Adrenogenital Syndrome)...

May 2022 36 pages

Congenital Ichthyosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Congenital Ichthyosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Congenital Ichthyosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 42 pages

Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 95 pages

Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Constipation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 56 pages

Filters

Search

Categories

2,264
2,910
126
9
6
1
1
1
4
522
3
6

Publishers

5,853

Regions

5,853

Price

Date

Pages

Offers